CA2477714A1 - Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments - Google Patents

Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments Download PDF

Info

Publication number
CA2477714A1
CA2477714A1 CA002477714A CA2477714A CA2477714A1 CA 2477714 A1 CA2477714 A1 CA 2477714A1 CA 002477714 A CA002477714 A CA 002477714A CA 2477714 A CA2477714 A CA 2477714A CA 2477714 A1 CA2477714 A1 CA 2477714A1
Authority
CA
Canada
Prior art keywords
enantiomers
racemates
mixtures
compounds
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002477714A
Other languages
English (en)
Other versions
CA2477714C (fr
Inventor
Rainer Soyka
Guenter Linz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2002109243 external-priority patent/DE10209243A1/de
Priority claimed from DE2002116124 external-priority patent/DE10216124A1/de
Application filed by Individual filed Critical Individual
Publication of CA2477714A1 publication Critical patent/CA2477714A1/fr
Application granted granted Critical
Publication of CA2477714C publication Critical patent/CA2477714C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La présente invention concerne de nouveaux sels d'acide cinnamique de salmétérol ainsi que des procédés de production et d'utilisation de ces sels comme médicaments.
CA2477714A 2002-03-04 2003-02-19 Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments Expired - Fee Related CA2477714C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10209243.5 2002-03-04
DE2002109243 DE10209243A1 (de) 2002-03-04 2002-03-04 Neue Arzneimittelkombination zur Inhalation
DE2002116124 DE10216124A1 (de) 2002-04-12 2002-04-12 Neue Zimtsäuresalze, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10216124.0 2002-04-12
PCT/EP2003/001644 WO2003074469A1 (fr) 2002-03-04 2003-02-19 Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments

Publications (2)

Publication Number Publication Date
CA2477714A1 true CA2477714A1 (fr) 2003-09-12
CA2477714C CA2477714C (fr) 2011-01-25

Family

ID=27789722

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2477714A Expired - Fee Related CA2477714C (fr) 2002-03-04 2003-02-19 Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments

Country Status (9)

Country Link
EP (1) EP1483231A1 (fr)
JP (1) JP2005519110A (fr)
AR (1) AR038622A1 (fr)
AU (1) AU2003221482A1 (fr)
CA (1) CA2477714C (fr)
PE (1) PE20030933A1 (fr)
TW (1) TW200404759A (fr)
UY (1) UY27686A1 (fr)
WO (1) WO2003074469A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2265276B1 (es) * 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310477D0 (en) * 1983-04-18 1983-05-25 Glaxo Group Ltd Chemical compounds
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
RU2081108C1 (ru) * 1991-10-16 1997-06-10 Циба-Гейги АГ Аддитивные соли кислот с основанием и фармацевтическая композиция, обладающая противоопухолевой активностью

Also Published As

Publication number Publication date
PE20030933A1 (es) 2003-12-15
EP1483231A1 (fr) 2004-12-08
JP2005519110A (ja) 2005-06-30
TW200404759A (en) 2004-04-01
AU2003221482A1 (en) 2003-09-16
AR038622A1 (es) 2005-01-19
WO2003074469A1 (fr) 2003-09-12
CA2477714C (fr) 2011-01-25
UY27686A1 (es) 2003-10-31

Similar Documents

Publication Publication Date Title
MY136034A (en) New medicaments for the treatment of chronic obstructive pulmonary disease
JP2002513793A5 (fr)
UA81635C2 (en) 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12.
JP2007532627A5 (fr)
WO2006018222A8 (fr) Nouveaux hydrates et polymorphes du 4-[[(7r)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-4-6-oxo-2-piperidinyl]amino]-3-methoxy-n-(1-methyl-4-piperidinyl)-benzamide, son procede de production et son utilisation comme medicament
WO2007082808A3 (fr) Thiazoles en tant qu'inhibiteurs de 11 beta-hsd1
JP2010503688A5 (fr)
CN1893948A (zh) 蕈毒碱性乙酰胆碱受体拮抗剂
TW200503674A (en) Therapeutic agents
MY130316A (en) Quaternary ammonium compounds
JP2005502635A5 (fr)
JP2005511698A5 (fr)
DE602006021539D1 (en) Morpholine als 5ht2c-agonisten
IL183636A0 (en) Quinoline derivative, use and production thereof, and drug containing the same
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
EP2269694A3 (fr) Composition antituberculeuse comprenant des composés d'oxazole
JP2012513390A5 (fr)
HRP20041202A2 (en) Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
JP2007514691A5 (fr)
JO2478B1 (en) (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
JP2005519989A5 (fr)
CA2477714A1 (fr) Nouveaux sels d'acide cinnamique, procedes de production et d'utilisation comme medicaments
CA2587891A1 (fr) Derives de la 1-[(alcoxyquinoxalinyle a substitution en 6,7)aminocarbonyl]-4-(hetero)alylpiperazine
CA2547243A1 (fr) Biphenylcarboxamides a substitution n-aryle piperidine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20140219